{"title":"免疫球蛋白治疗Covid-19急性呼吸窘迫综合征和急性心肌炎","authors":"Jebbar Nourddine","doi":"10.33552/asoaj.2021.02.000540","DOIUrl":null,"url":null,"abstract":"The novel corona virus disease (COVID-19) becomes a major public health. It was declared as pandemic by the World Health Organization on March 12, 2020.Myocarditis and myocardial injury are considered as one of the leading causes for death of COVID-19 Patients. The use of immunoglobulin seems to have an important role in the favorable evolution of these patients with cardiac involvement.","PeriodicalId":367766,"journal":{"name":"Anaesthesia & Surgery Open Access Journal","volume":"44 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Covid-19 Acute Respiratory Distress Syndrome And Acute Myocarditis Saved With Immunoglobulin\",\"authors\":\"Jebbar Nourddine\",\"doi\":\"10.33552/asoaj.2021.02.000540\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The novel corona virus disease (COVID-19) becomes a major public health. It was declared as pandemic by the World Health Organization on March 12, 2020.Myocarditis and myocardial injury are considered as one of the leading causes for death of COVID-19 Patients. The use of immunoglobulin seems to have an important role in the favorable evolution of these patients with cardiac involvement.\",\"PeriodicalId\":367766,\"journal\":{\"name\":\"Anaesthesia & Surgery Open Access Journal\",\"volume\":\"44 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anaesthesia & Surgery Open Access Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33552/asoaj.2021.02.000540\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesia & Surgery Open Access Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33552/asoaj.2021.02.000540","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Covid-19 Acute Respiratory Distress Syndrome And Acute Myocarditis Saved With Immunoglobulin
The novel corona virus disease (COVID-19) becomes a major public health. It was declared as pandemic by the World Health Organization on March 12, 2020.Myocarditis and myocardial injury are considered as one of the leading causes for death of COVID-19 Patients. The use of immunoglobulin seems to have an important role in the favorable evolution of these patients with cardiac involvement.